gabapentinoids 和慢性阻塞性肺部疾病恶化的风险
Yuya Kimura1, Taisuke Jo2, Norihiko Inoue3
1The University of Tokyo, Bunkyo-ku, Tokyo, Japan; yuk.close.to.wrd.34@gmail.com.
Annals of the American Thoracic Society
|July 16, 2025
概括
在患有慢性阻塞性肺病 (COPD) 的患者中使用 gabapentinoid 可能会增加恶化. 这项研究建议将COPD患者的 gabapentinoid 处方限制在必要情况下.
科学领域:
- 肺部医学 肺部医学
- 药理学 药理学是指药理学的学科.
- 临床研究 临床研究
背景情况:
- 有限的数据存在于慢性阻塞性肺病 (COPD) 患者的 gabapentinoid 影响.
- 美国食品和药物管理局 (FDA) 已对 gabapentinoids 发出安全警告,特别是对有呼吸风险的个人.
研究的目的:
- 为了确定加巴类药物的使用是否与COPD恶化的风险增加有关,需要全身皮质类固醇治疗.
主要方法:
- 一项回顾性队列研究利用了全国范围的行政索赔数据库.
- 患有COPD和开始使用 gabapentinoids 慢性疼痛的患者与三环抗抑郁药 (TCA) 和血清素-上腺素再吸收抑制剂 (SNRIs) 的新用户进行了比较.
- 倾向性得分权重组之间的平衡患者特征.
主要成果:
- 与TCA相比,使用 gabapentinoid 与需要全身皮质类固醇治疗的COPD恶化发生率更高相关 (HR: 1.21,1.03-1.42).
- 同样,与SNRIs相比,使用 gabapentinoid 显示这些恶化的发病率更高 (HR: 1.18,1.10-1.28).
结论:
- gabapentinoids 可能会增加COPD恶化的风险.
- 结果表明,在COPD和慢性疼痛患者中,可以明智地使用 gabapentinoids,并将其保留给具有明显益处的病例.
更多相关视频
相关概念视频
01:20Antiepileptic Drugs: Potassium Channel Activators
282
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
282
01:20COPD: Pathogenesis and Clinical Features
531
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
531
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K
01:22Chronic Obstructive Pulmonary Disease
1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.6K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.6K